Web Analytics

Start up Profile

Sift Biosciences

Sift Biosciences United States - San Carlos, CA
START UP

1 Disclosed Funding Rounds $3,700,000
0 Participating Investments




Using AI and high-throughput T-cell screening, Sift is developing a new class of T-cell modulators to treat cancers and autoimmune diseases.

Capital Raised

Date Round Raised Participating Investors
February, 19 ,2026 Pre-Seed $3,700,000